Stan Karbowiak: ‘The Man With the Golden Arm’ Changed the Fate of Millions of Babies
Stan Karbowiak, CEO and Founder – Medical and Wellness Information Specialist at MyHealthCRM, shared a post on LinkedIn:
“James Harrison’s story begins when he was a teenager recovering from major chest surgery in the 1950s, during which he received large amounts of donated blood to survive.
That experience left him determined to ‘give back’ once he was old enough to donate himself.
When he finally did, doctors discovered something extraordinary in his plasma: a rare antibody known as anti‑D, likely formed because of the transfusions he received as a boy.
This antibody turned out to be the key to preventing Rhesus disease, a condition that once caused thousands of newborn deaths each year.
Throughout the next six decades, Harrison donated plasma as often as Australian guidelines allowed, every two weeks, ultimately reaching 1,173 donations before mandatory age limits forced him to stop at 81.
His plasma was used to create ‘RhoGAM‑type injections’, which protect Rh‑negative mothers from developing antibodies that could attack their unborn babies.
Before this treatment existed, many women lost multiple pregnancies; after it became widespread, infant mortality from Rhesus disease plummeted across Australia.
Because his antibodies were so uniquely effective, Harrison became known nationwide as ‘The Man with the Golden Arm,’ and his donations are credited with saving over 2.5 million babies, a number so large that entire generations owe their lives to him.
Despite the fame, he remained humble, treating each donation like a simple errand rather than a heroic act. His legacy continues today through other anti‑D donors and ongoing research into lab‑made monoclonal antibodies that may one day replace the need for rare individuals like him.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering